Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.

Agreement includes investment to support clinical trials for potential first FDA-approved liquid embolic system for a peripheral vascular indication and option to acquire the company WOBURN, Mass., Dec. 9, 2020 -- (Healthcare Sales & Marketing Network) ... Devices, Oncology, Venture Capital Sirtex Medical, BlackSwan Vascular, Lava, liquid embolic, SIR-Spheres
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news